Elekta AB Gross Profit 2013-2024 | EKTAY
Elekta AB gross profit from 2013 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Elekta AB Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $638 |
| 2023 | $608 |
| 2022 | $612 |
| 2021 | $642 |
| 2020 | $637 |
| 2019 | $629 |
| 2018 | $573 |
| 2017 | $506 |
| 2016 | $548 |
| 2015 | $580 |
| 2014 | $712 |
| 2013 | $718 |
| 2012 | $640 |
| Elekta AB Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-07-31 | $133 |
| 2024-04-30 | $173 |
| 2024-01-31 | $160 |
| 2023-10-31 | $154 |
| 2023-07-31 | $150 |
| 2023-04-30 | $185 |
| 2023-01-31 | $158 |
| 2022-10-31 | $137 |
| 2022-07-31 | $128 |
| 2022-04-30 | $169 |
| 2022-01-31 | $147 |
| 2021-10-31 | $165 |
| 2021-07-31 | $132 |
| 2021-04-30 | $167 |
| 2021-01-31 | $165 |
| 2020-10-31 | $164 |
| 2020-07-31 | $146 |
| 2020-04-30 | $174 |
| 2020-01-31 | $161 |
| 2019-10-31 | $157 |
| 2019-07-31 | $145 |
| 2019-04-30 | $201 |
| 2019-01-31 | $150 |
| 2018-10-31 | $153 |
| 2018-07-31 | $125 |
| 2018-04-30 | $180 |
| 2018-01-31 | $139 |
| 2017-10-31 | $146 |
| 2017-07-31 | $107 |
| 2017-04-30 | $179 |
| 2017-01-31 | $117 |
| 2016-10-31 | $119 |
| 2016-07-31 | $91 |
| 2016-04-30 | $184 |
| 2016-01-31 | $118 |
| 2015-10-31 | $140 |
| 2015-07-31 | $106 |
| 2015-04-30 | $175 |
| 2015-01-31 | $105 |
| 2014-10-31 | $135 |
| 2014-07-31 | $80 |
| 2014-04-30 | $248 |
| 2014-01-31 | $144 |
| 2013-10-31 | $160 |
| 2013-07-31 | $122 |
| 2013-04-30 | $271 |
| 2013-01-31 | $165 |
| 2012-10-31 | $174 |
| 2012-07-31 | $106 |
| 2012-04-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.596B | $1.704B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.667B | 27.41 |
| Intuitive Surgical (ISRG) | United States | $171.263B | 96.97 |
| Alcon (ALC) | Switzerland | $47.978B | 33.77 |
| IQVIA Holdings (IQV) | United States | $41.900B | 23.74 |
| Edwards Lifesciences (EW) | United States | $39.451B | 25.29 |
| IDEXX Laboratories (IDXX) | United States | $39.315B | 47.29 |
| DexCom (DXCM) | United States | $27.294B | 38.92 |
| STERIS (STE) | Ireland | $22.783B | 26.58 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.950B | 0.00 |
| Waters (WAT) | United States | $20.926B | 31.20 |
| Hologic (HOLX) | United States | $18.638B | 20.26 |
| Sysmex ADR (SSMXY) | Japan | $12.525B | 39.28 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.147B | 13.62 |
| Teleflex (TFX) | United States | $11.269B | 17.52 |
| Globus Medical (GMED) | United States | $9.568B | 26.77 |
| Penumbra (PEN) | United States | $7.564B | 78.52 |
| Masimo (MASI) | United States | $7.385B | 39.55 |
| Glaukos (GKOS) | United States | $7.197B | 0.00 |
| TransMedics (TMDX) | United States | $4.636B | 198.53 |
| Integer Holdings (ITGR) | United States | $4.329B | 25.32 |
| PROCEPT BioRobotics (PRCT) | United States | $3.773B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.923B | 17.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.735B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.599B | 16.17 |
| Veracyte (VCYT) | United States | $2.523B | 156.38 |
| Inari Medical (NARI) | United States | $2.443B | 0.00 |
| RxSight (RXST) | United States | $1.809B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.319B | 6.01 |
| Artivion (AORT) | United States | $1.108B | 101.69 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.066B | 19.02 |
| OPKO Health (OPK) | United States | $1.039B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.979B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.771B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.723B | 18.25 |
| IRadimed (IRMD) | United States | $0.631B | 34.12 |
| OrthoPediatrics (KIDS) | United States | $0.628B | 0.00 |
| SiBone (SIBN) | United States | $0.612B | 0.00 |
| AxoGen (AXGN) | United States | $0.599B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.584B | 0.00 |
| Paragon 28 (FNA) | United States | $0.491B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.469B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.343B | 10.47 |
| Treace Medical Concepts (TMCI) | United States | $0.332B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.309B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.292B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.248B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.244B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| NeuroPace (NPCE) | United States | $0.199B | 0.00 |
| Accuray (ARAY) | United States | $0.192B | 0.00 |
| CVRx (CVRX) | United States | $0.191B | 0.00 |
| Nevro (NVRO) | United States | $0.185B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.185B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.175B | 12.25 |
| Alpha Tau Medical (DRTS) | Israel | $0.159B | 0.00 |
| 908 Devices (MASS) | United States | $0.121B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.120B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.119B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.103B | 15.34 |
| EDAP TMS S.A (EDAP) | France | $0.098B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.066B | 0.00 |
| Envoy Medical (COCH) | United States | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.063B | 0.00 |
| LENSAR (LNSR) | United States | $0.052B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.046B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.034B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.032B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.028B | 0.00 |
| Neuronetics (STIM) | United States | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| Spectral AI (MDAI) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |